Literature DB >> 28451703

[Inflammatory cardiomyopathy and myocarditis].

B Maisch1,2, A D Ristic3, S Pankuweit4,5.   

Abstract

We describe diagnosis, differential diagnosis, multimodality imaging and medical and invasive diagnostic treatment in patients with inflammatory cardiomyopathy and myocarditis under etiological considerations in reference to a landmark position paper of the Working Group Myocardial and Pericardial Diseases of the European Society of Cardiology together with recent developments in diagnosis and treatment. Diagnosis of the symptomatic patient is the assessment of etiology of inflammatory cardiomyopathy, followed by the clinical presentation, course, treatment option and prognosis. Viral myocarditis in its different facets can clearly be separated from autoreactive forms by histological and molecular methods in the endomyocardial biopsy, thus leading to an individualized targeted therapy beyond heart failure treatment.

Entities:  

Keywords:  Cardiomyopathies; Echocardiography; Endomyocardial biopsy; Myocarditis; Pericarditis

Mesh:

Year:  2017        PMID: 28451703     DOI: 10.1007/s00059-017-4569-y

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.740


  54 in total

1.  Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results.

Authors:  R Wojnicz; E Nowalany-Kozielska; C Wojciechowska; G Glanowska; P Wilczewski; T Niklewski; M Zembala; L Polonski; M M Rozek; J Wodniecki
Journal:  Circulation       Date:  2001-07-03       Impact factor: 29.690

2.  Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.

Authors:  Alida L P Caforio; Sabine Pankuweit; Eloisa Arbustini; Cristina Basso; Juan Gimeno-Blanes; Stephan B Felix; Michael Fu; Tiina Heliö; Stephane Heymans; Roland Jahns; Karin Klingel; Ales Linhart; Bernhard Maisch; William McKenna; Jens Mogensen; Yigal M Pinto; Arsen Ristic; Heinz-Peter Schultheiss; Hubert Seggewiss; Luigi Tavazzi; Gaetano Thiene; Ali Yilmaz; Philippe Charron; Perry M Elliott
Journal:  Eur Heart J       Date:  2013-07-03       Impact factor: 29.983

3.  Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy.

Authors:  D M McNamara; W D Rosenblum; K M Janosko; M K Trost; F S Villaneuva; A J Demetris; S Murali; A M Feldman
Journal:  Circulation       Date:  1997-06-03       Impact factor: 29.690

4.  Therapeutic effect of immunoadsorption and subsequent immunoglobulin substitution in patients with dilated cardiomyopathy: Results from the observational prospective Bad Berka Registry.

Authors:  Marc-Alexander Ohlow; Michele Brunelli; Matthias Schreiber; Bernward Lauer
Journal:  J Cardiol       Date:  2016-11-24       Impact factor: 3.159

5.  Occurrence of late gadolinium enhancement is associated with increased left ventricular wall stress and mass in patients with non-ischaemic dilated cardiomyopathy.

Authors:  Peter Alter; Heinz Rupp; Philipp Adams; Florian Stoll; Jens H Figiel; Klaus J Klose; Marga B Rominger; Bernhard Maisch
Journal:  Eur J Heart Fail       Date:  2011-07-28       Impact factor: 15.534

6.  Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders.

Authors:  Andrea Frustaci; Cristina Chimenti; Fiorella Calabrese; Maurizio Pieroni; Gaetano Thiene; Attilio Maseri
Journal:  Circulation       Date:  2003-02-18       Impact factor: 29.690

7.  Immunosuppressive treatment in autoreactive myocarditis--results from a controlled trial.

Authors:  B Maisch; U Schönian; C Hengstenberg; M Herzum; G Hufnagel; C Bethge; A Bittinger; K Neumann
Journal:  Postgrad Med J       Date:  1994       Impact factor: 2.401

Review 8.  Integrated biomarkers in cardiomyopathies: cardiovascular magnetic resonance imaging combined with molecular and immunologic markers--a stepwise approach for diagnosis and treatment.

Authors:  Jeanette Schulz-Menger; Bernhard Maisch; Hassan Abdel-Aty; Sabine Pankuweit
Journal:  Herz       Date:  2007-09       Impact factor: 1.443

9.  Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens.

Authors:  Sabine Pankuweit; R Moll; U Baandrup; Irene Portig; Günter Hufnagel; Bernhard Maisch
Journal:  Hum Pathol       Date:  2003-05       Impact factor: 3.466

10.  Long-term outcome of patients with virus-negative chronic myocarditis or inflammatory cardiomyopathy after immunosuppressive therapy.

Authors:  Felicitas Escher; Uwe Kühl; Dirk Lassner; Wolfgang Poller; Dirk Westermann; Burkert Pieske; Carsten Tschöpe; Heinz-Peter Schultheiss
Journal:  Clin Res Cardiol       Date:  2016-06-16       Impact factor: 5.460

View more
  1 in total

Review 1.  Treatment options in myocarditis and inflammatory cardiomyopathy : Focus on i. v. immunoglobulins.

Authors:  B Maisch; P Alter
Journal:  Herz       Date:  2018-08       Impact factor: 1.443

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.